Zhaoke Ophthalmology Limited
HKEX:6622.HK
1.37 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.723 | 3.723 | 5.652 | 5.652 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.677 | 1.677 | 0.575 | 0.575 | 2.833 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 2.047 | 2.047 | 5.077 | 5.077 | -2.833 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.55 | 0.55 | 0.898 | 0.898 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 63.852 | 63.852 | 102.673 | 102.673 | 97.751 | 97.751 | 50.465 | 50.465 | 48.312 | 48.312 | 61.718 | 61.718 | 27.06 | 19.044 | 19.044 | 18.647 |
| General & Administrative Expenses
| 20.917 | 20.917 | 21.285 | 21.285 | 23.3 | 23.3 | 19.755 | 19.755 | 30.734 | 30.734 | 50.306 | 50.306 | 26.006 | 2.735 | 2.735 | 2.647 |
| Selling & Marketing Expenses
| 14.407 | 14.407 | 11.538 | 11.538 | 8.145 | 8.145 | 6.828 | 6.828 | 5.085 | 5.085 | 3.283 | 3.283 | 1.542 | 0 | 0 | 0 |
| SG&A
| 35.324 | 35.324 | 32.822 | 32.822 | 31.445 | 31.445 | 26.583 | 26.583 | 35.819 | 35.819 | 53.589 | 53.589 | 27.548 | 2.735 | 2.735 | 2.647 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 114.229 | 114.229 | 119.878 | 119.878 | 137.436 | 137.436 | 79.86 | 79.86 | 73.05 | 73.05 | 993.383 | 993.383 | 151.608 | 32.901 | 32.901 | 32.834 |
| Operating Income
| -96.435 | -96.435 | -130.419 | -130.419 | -129.122 | -129.122 | -77.048 | -77.048 | -84.127 | -84.127 | -115.307 | -115.307 | -54.608 | -21.779 | -21.779 | -21.294 |
| Operating Income Ratio
| -25.902 | -25.902 | -23.075 | -23.075 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 20.81 | 20.81 | 13.8 | 13.8 | 5.976 | 5.976 | -3.466 | -3.466 | 13.066 | 13.066 | -878.523 | -878.523 | -96.894 | -11.497 | -11.497 | -10.641 |
| Income Before Tax
| -75.625 | -75.625 | -116.619 | -116.619 | -123.146 | -123.146 | -80.513 | -80.513 | -71.061 | -71.061 | -993.829 | -993.829 | -151.502 | -33.276 | -33.276 | -31.935 |
| Income Before Tax Ratio
| -20.313 | -20.313 | -20.633 | -20.633 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.005 | 0.005 | 0.27 | 0.27 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -75.63 | -75.63 | -116.889 | -116.889 | -123.146 | -123.146 | -80.513 | -80.513 | -71.061 | -71.061 | -993.829 | -993.829 | -151.502 | -33.276 | -33.276 | -31.935 |
| Net Income Ratio
| -20.314 | -20.314 | -20.681 | -20.681 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.14 | -0.14 | -0.22 | -0.22 | -0.23 | -0.23 | -0.15 | -0.15 | -0.13 | -0.13 | -3.51 | -3.51 | -1 | -0.21 | -0.21 | -0.2 |
| EPS Diluted
| -0.14 | -0.14 | -0.21 | -0.21 | -0.23 | -0.23 | -0.15 | -0.15 | -0.13 | -0.13 | -3.51 | -3.51 | -1 | -0.21 | -0.21 | -0.2 |
| EBITDA
| -90.038 | -90.038 | -119.977 | -119.977 | -122.318 | -122.318 | -69.959 | -69.959 | -78.195 | -78.195 | -110.569 | -110.569 | -50.287 | -18.467 | -18.467 | -17.768 |
| EBITDA Ratio
| -24.184 | -24.184 | -21.227 | -21.227 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |